Action APPAD HERON THERAPEUTICS INC
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Heron Therapeutics Inc OTC Bulletin Board

Actions

APPAD

US4277461020

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Heron Therapeutics Announces the Inclusion of ZYNRELEF as a Qualifying Product under the Proposed 2025 Non-Opioid Policy for Pain Relief under the OPPS and the ASC Payment System
Heron Therapeutics Says Non-Opioid Pain Medication to be Included in Proposed Medicare Programs
Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System
Heron Therapeutics, Inc. Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System
Heron Reports Acceptance of Prior Approval Supplement Application for Zynrelef Vial Access Needle
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")
Heron Therapeutics, Inc. Announces Acceptance of the Prior Approval Supplement Application for Zynrelef® Vial Access Needle
Heron Therapeutics, Inc.(NasdaqCM:HRTX) added to S&P Biotechnology Select Industry Index
Connect Biopharma Names New Chief Executive, Chair
Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")
Heron Therapeutics, Inc. Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")
Heron Therapeutics : Investor Day Presentation
Heron Therapeutics: Q1 Earnings Snapshot
Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Heron Therapeutics, Inc. Re-Affirms Earnings Guidance for the Full Year 2024
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action HRTX
  4. Action APPAD
  5. Actualités Heron Therapeutics Inc
  6. Autres langues